
USD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$15.41M
Market Cap
-
P/E Ratio
-1.13
EPS
$1.10
52 Week High
$0.15
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$782 |
| Total Revenue | $0 |
| Cost Of Revenue | $782 |
| Costof Goods And Services Sold | $782 |
| Operating Income | -$12M |
| Selling General And Administrative | $4.8M |
| Research And Development | $7.3M |
| Operating Expenses | $12M |
| Investment Income Net | - |
| Net Interest Income | $201K |
| Interest Income | $201K |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $782 |
| Income Before Tax | -$12M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$12M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$12M |
| Ebitda | -$12M |
| Net Income | -$12M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$782 |
| Total Revenue | $0 |
| Cost Of Revenue | $782 |
| Costof Goods And Services Sold | $782 |
| Operating Income | -$12M |
| Selling General And Administrative | $4.8M |
| Research And Development | $7.3M |
| Operating Expenses | $12M |
| Investment Income Net | - |
| Net Interest Income | $201K |
| Interest Income | $201K |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $782 |
| Income Before Tax | -$12M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$12M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$12M |
| Ebitda | -$12M |
| Net Income | -$12M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Processa Pharmaceuticals, Inc. (PCSA) is a clinical-stage biopharmaceutical company based in Hanover, Maryland, specializing in the development of innovative therapies for unmet medical needs. With a robust portfolio of proprietary drug candidates, the firm is actively advancing through rigorous clinical trials to address significant health challenges, particularly in under-served therapeutic areas. By prioritizing patient outcomes and striving to enhance quality of life, Processa Pharmaceuticals positions itself as a compelling investment opportunity within the dynamic and rapidly evolving healthcare landscape.